by John Conrad | May 27, 2026 | iBIO in the News, Policy News
Yesterday in Springfield, iBIO President and CEO John Conrad testified on legislation that would expand and reshape how Illinois interacts with the federal 340B drug discount program—underscoring a principle iBIO believes must come first: independent, enforceable...
by John Conrad | May 13, 2026 | Policy News
As Congress debates Most Favored Nation (MFN) drug pricing — a policy that would peg Medicare drug prices to rates paid in other high-income countries — two new reports put the stakes in sharp relief. The picture for patients and for Illinois is not a good one. A new...
